Use of pyrazolopyridines for the treatment of cognitive deficits

Details for Australian Patent Application No. 2004251466 (hide)

Owner Exonhit Therapeutics SA

Inventors Schweighoffer, Fabien; Rouquette, Magali; Resink, Annelies; Desire, Laurent

Agent Davies Collison Cave

Pub. Number AU-B-2004251466

PCT Pub. Number WO2005/000302

Priority 03/07824 27.06.03 FR

Filing date 25 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 7 January 2010

International Classifications

A61K 31/437 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000302 Priority application(s): WO2005/000302

7 January 2010 Application Accepted

  Published as AU-B-2004251466

6 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251467-Post-discharge plasma sterilisation device and method

2004251462-Method for identification of Tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof